Dimethyl fumarate ameliorates parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis
Brain Research · 2023-09 · 1815 · 148462
DOI: 10.1016/j.brainres.2023.148462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2023-09. Verfasst von Mayuri Khot und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular & Cellular Neuroscience Lab, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)…. Hauptthemen laut MEDLINE: Dimethyl Fumarate, NF-E2-Related Factor 2. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.
Abstract (Originalsprache)
Mounting evidence suggests a role for oxidative stress and accumulation of dysfunctional organelle and misfolded proteins in PD. Autophagosomes mediate the clearance of these cytoplasmic proteins via delivery to lysosomes to form autophagolysosomes, followed by degradation of the protein by lysosomal enzymes. In PD, autophagolysosome accumulation occurs initiating a plethora of events resulting in neuronal death by apoptosis. This study evaluated the effect of Dimethylfumarate (DMF), an Nrf2 activator in the rotenone-induced mouse PD model. In PD mice, there was decreased expression of LAMP2 and LC3, which resulted in inhibition of autophagic flux and increased expression of cathepsin D, which mediated apoptosis. The role of Nrf2 activation in alleviating oxidative stress is well known. Our study elucidated the novel mechanism underlying the neuroprotective effect of DMF. The loss of dopaminergic neurons induced by rotenone was lessened to a significant extent by pre-treatment with DMF. DMF promoted autophagosome formation and inhibited apoptosis by removing the inhibitory effect of p53 on TIGAR. TIGAR expression upregulated LAMP2 expression and downregulated Cathepsin D, promoting autophagy and inhibiting apoptosis. Thus, it was proved that DMF confers neuroprotection against rotenone-induced dopaminergic neurodegeneration and could be used as a potential therapeutic agent for PD and its progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular & Cellular Neuroscience Lab, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, Telangana, India.
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, Telangana, India.
- Molecular & Cellular Neuroscience Lab, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, Telangana, India. Electronic address: dkkhatri10@g…
Förderung
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
Zitieren
APA
Khot, M., Sood, A., Tryphena, K. P., Pinjala, P., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023). Dimethyl fumarate ameliorates parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis. Brain Research, 1815, 148462. https://doi.org/10.1016/j.brainres.2023.148462
Vancouver
Khot M, Sood A, Tryphena KP, Pinjala P, Srivastava S, Singh SB, et al. Dimethyl fumarate ameliorates parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis. Brain Research. 2023;1815:148462. doi:10.1016/j.brainres.2023.148462
BibTeX
@article{Khot2023,
author = {Khot, Mayuri and Sood, Anika and Tryphena, Kamatham Pushpa and Pinjala, Poojitha and Srivastava, Saurabh and Singh, Shashi Bala and Khatri, Dharmendra Kumar},
title = {Dimethyl fumarate ameliorates parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis},
journal = {Brain Research},
year = {2023},
volume = {1815},
pages = {148462},
doi = {10.1016/j.brainres.2023.148462}
}
EUVIMED